Clinical trials recruiting for Chronic Heart Failure

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure
  NCT07265349 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 4 locations
• A Study to Learn More About How Safe Finerenone is and How Well it Works in Adults With Chronic Heart Failure in South Korea
  NCT07379840 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• A Study to Learn More About the Safety of the Drug Vericiguat in Japanese People With Chronic Heart Failure Who Will be Receiving Vericiguat Under Real-world Conditions
  NCT05666518 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• AI-Based Monitoring System for Chronic Heart Failure With Advanced Wearable and Mini-Invasive Devices
  NCT06909682 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Acetazolamide Per os for Decompensation of Heart Failure
  NCT05802849 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Biomarkers as Predictors of Chronic Heart Failure in Patients With Type 2 Diabetes
  NCT04941794 · Phase: Not specified · Ages: 50 Years and older · Sex: All (male and female) · 1 location
• Biventricular or Left Bundle Branch Pacing to Assess the Effect of Cardiac Resynchronization Therapy in Patients Undergoing Transcatheter Aortic Valve Implantation
  NCT07434193 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• CHF-COV Reduced (Chronic Heart Failure With Reduced Ejection Fraction - COngestion eValuation)
  NCT05089162 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment
  NCT05327062 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 13 locations
• Chronic Heart Failure - COngestion eValuation
  NCT05089149 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Chronic Heart Failure With Preserved Ejection Fraction - COngestion eValuation
  NCT05097898 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Comparing the Effects of Combining Cognitive and Physical Exercise Training on Cognition, and Cerebral Blood Flow Regulation in Men and Women With Chronic Heart Failure
  NCT04970888 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years and older · Sex: All (male and female) · 1 location
• Effect of Empagliflozin on Quality of Life in Chronic Heart Failure Patients With Diabetes Mellitus Type II
  NCT06706791 · Phase: Phase 4 · Ages: 40 Years to 70 Years · Sex: All (male and female) · 1 location
• Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure
  NCT06270498 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure
  NCT06423599 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Effectiveness of Low -Versus High -Volume High -Intensity Interval Training in Patients With Chronic Heart Failure
  NCT07325942 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Impact of YOGA on the Quality of Life and Well-being of Heart Failure Patients
  NCT06019169 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure
  NCT07490054 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
  NCT05934565 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · 4 locations
• Mobile-Based Telemedicine and Health-Related Quality of Life Among Patients With Chronic Heart Failure (MOBILE-HF)
  NCT07650474 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
  NCT06929806 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Multiple-biomarker Approach for Individualized Treatment of Heart Failure with Preserved Ejection Fraction
  NCT06785506 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• National Heart Failure Registry
  NCT06683001 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Non-invasive Ventilation and High-speed Oxygen Therapy Effects on Heart Function - HiFlow-Heart Study
  NCT04471129 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Patient SELF-management With HemodynamIc Monitoring: Virtual Heart Failure Clinic and Outcomes
  NCT04441203 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
  NCT06360380 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 79 Years · Sex: All (male and female) · 10 locations
• Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI
  NCT07149714 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Effect of Exercise Training and Detraining on Frailty and Fall Risk in Patients With Chronic Heart Failure
  NCT06036615 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• The HEARTFELT Study
  NCT06222099 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years and older · Sex: All (male and female) · 3 locations
• The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)
  NCT05793996 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
  NCT03945968 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 76 locations
• Vericiguat and Reverse Remodeling Indices in Heart Failure
  NCT07405944 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Chronic Heart Failure often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Chronic Heart Failure trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.